During the past decade, Willamette Valley Clinical Studies conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 10 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Willamette Valley Clinical Studies" #1 sponsor was "AstraZeneca" with 6 trials, followed by "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Novartis" with 2 trials sponsored, "Pronova BioPharma" with 2 trials sponsored and "Arisaph Pharmaceuticals Inc" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Willamette Valley Clinical Studies" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Integrium" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Willamette Valley Clinical Studies" are "Type 2 Diabetes" (4 trials), "Diabetes Mellitus, Type 2" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Dyslipidemia" (2 trials) and "Low Back Pain" (2 trials). Many other conditions were trialed in "Willamette Valley Clinical Studies" in a lesser frequency.

Most popular intervention types in "Willamette Valley Clinical Studies" are "Drug" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Dapagliflozin" (5 trials), "Metformin XR" (3 trials), "Aprocitentan 25 mg" (2 trials) and "PRC-4016" (2 trials). Other intervention names were less common.

The vast majority of trials in "Willamette Valley Clinical Studies" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Willamette Valley Clinical Studies". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Willamette Valley Clinical Studies, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Willamette Valley Clinical Studies, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".